vcfirmsdirectory.com

Growth equity · Growth stage · Est. 1990

Galen Partners

Galen Partners is a Stamford, Connecticut investor that works only in healthcare and specializes in growth equity. It has backed healthcare companies since 1990.

StamfordRegistered · United States
New investments · 12 months
Fund vehiclesPublic
8
8 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:05 CETSources: galen.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Galen Partners joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Galen Partners right for your round?

Is Galen Partners a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
8
8 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

GALEN PARTNERS VI, L.P.US private fund · Active · United States · $28.7M gross assets · filed 30 Apr 2026
GALEN PARTNERS V, L.P.US private fund · Active · United States · $24.5M gross assets · filed 30 Apr 2026
GALEN EVOLVE SPV LLCUS private fund · Active · United States · $7.2M gross assets · filed 30 Apr 2026
GALEN PARTNERS VI ANNEX FUND, L.P.US private fund · Active · United States · $3.9M gross assets · filed 30 Apr 2026
GALEN PARTNERS INTERNATIONAL V, L.P.US private fund · Active · United States · $2.6M gross assets · filed 30 Apr 2026
GALEN CDX SPV LLCUS private fund · Active · United States · $1.9M gross assets · filed 30 Apr 2026
GALEN CDX SPV II LLCUS private fund · Active · United States · $1.8M gross assets · filed 30 Apr 2026
GALEN CDX SPV III LLCUS private fund · Active · United States · $157.9K gross assets · filed 30 Apr 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds Galen Partners joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round Galen Partners joined

Round sizes, Galen Partners’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

Acura PharmaceuticalsAperioCambrooke Medical FoodsDow Pharmaceutical SciencesEncore MedicalJDS PharmaceuticalsLumenosMiniMedNational Rehab EquipmentNautilus Neurosciencesand 1 more

Portfolio and exits

Every company Galen Partners backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Galen Partners puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Galen Partners

Events where Galen Partners’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Galen Partners’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

30 Apr 2026Fund filingForm ADV filed by GALEN HEALTHCARE MANAGEMENT, LLC: 6 private funds, $43.6M in gross assets.SEC Form ADV · public record
30 Apr 2026Fund filingForm ADV filed by GALEN MANAGEMENT, LLC: 2 private funds, $27M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

Galen Partners is based in the United States. It also has an office in Stamford.

In 1990.

8 fund vehicles are on public registers (SEC adviser filings), including GALEN PARTNERS VI, L.P., GALEN PARTNERS V, L.P. and GALEN EVOLVE SPV LLC.

Stages: Growth. Sectors: Medtech, Biotech. From the firm’s own website.

Galen expects healthcare to change more in the next decade than in the past fifty years. It backs proven, scaling healthcare companies that improve outcomes, lower cost, or both, and supports them through a hands-on approach it calls Collaborative Capital. From the firm’s own website.

Galen Partners lists 11 portfolio companies on its website, including Acura Pharmaceuticals, Aperio, Cambrooke Medical Foods, Dow Pharmaceutical Sciences and Encore Medical.

Firms whose websites list some of the same companies include Data Point Capital, Jump Capital and Output Capital.

Know before Galen Partners’s next round is announced.

PRO tracks Galen Partners’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Galen PartnersGet Galen Partners’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.